-
Something wrong with this record ?
Evaluation of Second-Generation Lipophosphonoxins as Antimicrobial Additives in Bone Cement
E. Zborníková, J. Gallo, R. Večeřová, K. Bogdanová, M. Kolář, D. Vítovská, DD. Do Pham, O. Pačes, V. Mojr, H. Šanderová, J. Ulrichová, A. Galandáková, D. Čadek, Z. Hrdlička, L. Krásný, D. Rejman
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't, Evaluation Study
Grant support
NV17-29680A
MZ0
CEP Register
Digital library NLK
Full text - Article
NLK
Directory of Open Access Journals
from 2016
PubMed Central
from 2016
Europe PubMed Central
from 2016
ROAD: Directory of Open Access Scholarly Resources
from 2016
- Keywords
- lipofosfonoxiny,
- MeSH
- Anti-Infective Agents * analysis therapeutic use MeSH
- Biofilms MeSH
- Gram-Positive Bacteria MeSH
- Hydrophobic and Hydrophilic Interactions MeSH
- Imino Sugars analysis therapeutic use MeSH
- Prosthesis-Related Infections prevention & control MeSH
- Bone Cements * analysis therapeutic use MeSH
- Humans MeSH
- Microbial Sensitivity Tests methods MeSH
- Nucleosides analysis therapeutic use MeSH
- Organophosphonates analysis therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Research Support, Non-U.S. Gov't MeSH
Successful surgeries involving orthopedic implants depend on the avoidance of biofilm development on the implant surface during the early postoperative period. Here, we investigate the potential of novel antibacterial compounds-second-generation lipophosphonoxins (LPPOs II)-as additives to surgical bone cements. We demonstrate (i) excellent thermostability of LPPOs II, which is essential to withstand elevated temperatures during exothermic cement polymerization; (ii) unchanged tensile strength and elongation at the break properties of the composite cements containing LPPOs II compared to cements without additives; (iii) convenient elution kinetics on the order of days; and (iv) the strong antibiofilm activity of the LPPO II-loaded cements even against bacteria resistant to the medicinally utilized antibiotic, gentamicin. Thus, LPPOs II display promising potential as antimicrobial additives to surgical bone cements.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22008252
- 003
- CZ-PrNML
- 005
- 20230112150156.0
- 007
- ta
- 008
- 220317s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acsomega.9b03072 $2 doi
- 035 __
- $a (PubMed)32118132
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Zborníková, Eva $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic $u Department of Analytical Chemistry, Faculty of Science, Charles University Prague, Hlavova 8, 128 43 Prague 2, Czech Republic
- 245 10
- $a Evaluation of Second-Generation Lipophosphonoxins as Antimicrobial Additives in Bone Cement / $c E. Zborníková, J. Gallo, R. Večeřová, K. Bogdanová, M. Kolář, D. Vítovská, DD. Do Pham, O. Pačes, V. Mojr, H. Šanderová, J. Ulrichová, A. Galandáková, D. Čadek, Z. Hrdlička, L. Krásný, D. Rejman
- 520 9_
- $a Successful surgeries involving orthopedic implants depend on the avoidance of biofilm development on the implant surface during the early postoperative period. Here, we investigate the potential of novel antibacterial compounds-second-generation lipophosphonoxins (LPPOs II)-as additives to surgical bone cements. We demonstrate (i) excellent thermostability of LPPOs II, which is essential to withstand elevated temperatures during exothermic cement polymerization; (ii) unchanged tensile strength and elongation at the break properties of the composite cements containing LPPOs II compared to cements without additives; (iii) convenient elution kinetics on the order of days; and (iv) the strong antibiofilm activity of the LPPO II-loaded cements even against bacteria resistant to the medicinally utilized antibiotic, gentamicin. Thus, LPPOs II display promising potential as antimicrobial additives to surgical bone cements.
- 650 17
- $a kostní cementy $x analýza $x terapeutické užití $7 D001843 $2 czmesh
- 650 17
- $a antiinfekční látky $x analýza $x terapeutické užití $7 D000890 $2 czmesh
- 650 _7
- $a nukleosidy $x analýza $x terapeutické užití $7 D009705 $2 czmesh
- 650 _7
- $a iminosacharidy $x analýza $x terapeutické užití $7 D050111 $2 czmesh
- 650 _7
- $a organofosfonáty $x analýza $x terapeutické užití $7 D063065 $2 czmesh
- 650 _7
- $a biofilmy $7 D018441 $2 czmesh
- 650 _7
- $a infekce spojené s protézou $x prevence a kontrola $7 D016459 $2 czmesh
- 650 _7
- $a hydrofobní a hydrofilní interakce $7 D057927 $2 czmesh
- 650 _7
- $a grampozitivní bakterie $7 D006094 $2 czmesh
- 650 _7
- $a mikrobiální testy citlivosti $x metody $7 D008826 $2 czmesh
- 650 _7
- $a lidé $7 D006801 $2 czmesh
- 653 00
- $a lipofosfonoxiny
- 655 _2
- $a časopisecké články $7 D016428
- 655 _7
- $a práce podpořená grantem $7 D013485 $2 czmesh
- 655 _7
- $a hodnotící studie $7 D023362 $2 czmesh
- 700 1_
- $a Gallo, Jiří $u Department of Orthopedics, Faculty of Medicine and Dentistry, Palacký University Olomouc, I.P. Pavlova 6, 775 20 Olomouc, Czech Republic $7 xx0019005
- 700 1_
- $a Večeřová, Renata $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 775 15 Olomouc, Czech Republic $7 xx0114985
- 700 1_
- $a Bogdanová, Kateřina $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 775 15 Olomouc, Czech Republic $7 xx0252810
- 700 1_
- $a Kolář, Milan, $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 775 15 Olomouc, Czech Republic $d 1964- $7 jn20010310083
- 700 1_
- $a Vítovská, Dragana $u Institute of Microbiology, Czech Academy of Sciences v.v.i., Vídeňská 1083, 142 20 Prague 4, Czech Republic
- 700 1_
- $a Do Pham, Duy Dinh $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic
- 700 1_
- $a Pačes, Ondřej $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic $7 xx0117726
- 700 1_
- $a Mojr, Viktor $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic
- 700 1_
- $a Šanderová, Hana $u Institute of Microbiology, Czech Academy of Sciences v.v.i., Vídeňská 1083, 142 20 Prague 4, Czech Republic $7 xx0211001
- 700 1_
- $a Ulrichová, Jitka, $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 775 15 Olomouc, Czech Republic $d 1956- $7 ola2002158251
- 700 1_
- $a Galandáková, Adéla, $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 775 15 Olomouc, Czech Republic $d 1979- $7 stk2008428623
- 700 1_
- $a Čadek, Drahomír $u Department of Polymers, University of Chemistry and Technology Prague, Technická 5, Dejvice, 166 28 Praha 6, Czech Republic
- 700 1_
- $a Hrdlička, Zdeněk $u Department of Polymers, University of Chemistry and Technology Prague, Technická 5, Dejvice, 166 28 Praha 6, Czech Republic
- 700 1_
- $a Krásný, Libor $u Institute of Microbiology, Czech Academy of Sciences v.v.i., Vídeňská 1083, 142 20 Prague 4, Czech Republic $7 xx0142527
- 700 1_
- $a Rejman, Dominik $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic $7 xx0086093
- 773 0_
- $w MED00207589 $t ACS Omega $x 2470-1343 $g Roč. 5, č. 7 (2020), s. 3165-3171
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32118132 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220317 $b ABA008
- 991 __
- $a 20230112150149 $b ABA008
- 999 __
- $a kom $b bmc $g 1770957 $s 1159446
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 5 $c 7 $d 3165-3171 $e 20200212 $i 2470-1343 $m ACS omega $n ACS Omega $x MED00207589
- GRA __
- $a NV17-29680A $p MZ0
- LZP __
- $c NLK120 $d 20230112 $a 2021-granty